Trademark Overview
On Friday, June 6, 2025, a trademark application was filed for ORXES with the United States Patent and Trademark Office. The USPTO has given the ORXES trademark a serial number of 99221711. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 27, 2026. This trademark is owned by ORxes Therapeutics Co., Ltd.. The ORXES trademark is filed in the Pharmaceutical Products category with the following description:
Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Plant extracts, other than essential oils, for pharmaceutical purposes; Diagnostic preparations for medical purposes; Medicated shampoo; Biologics in the nature of pharmaceutical preparations for the treatment of pulmonary arterial hypertension, hypertension, and stroke; Biological preparations for the prevention and treatment of pulmonary arterial hypertension, hypertension, and stroke
